Difficulty: Medium
Average Score: 77%
Practice
Which of the following sympathomimetics is not a catecholamine:
Correct answer
C
Rationale
In understanding the question about sympathomimetics and catecholamines, it is essential to delve into the pharmacological characteristics of each option. Catecholamines are a specific group of neurotransmitters that include dopamine, adrenaline, and noradrenaline. The key characteristic of catecholamines is the presence of a catechol (benzene ring with two hydroxyl side groups) structure.
In this context, the correct answer is C) Amphetamine because amphetamine is not a catecholamine. While amphetamine does exert sympathomimetic effects by increasing the release of norepinephrine and dopamine, it lacks the catechol structure necessary to be classified as a catecholamine.
A) Adrenaline (epinephrine) and B) Noradrenaline (norepinephrine) are both catecholamines with the characteristic catechol ring structure, making them true members of this group. D) Isoprenaline (isoproterenol) is also a catecholamine with a similar structure to adrenaline and noradrenaline.
Educationally, this question helps reinforce the importance of understanding the chemical structures and classifications of drugs in pharmacology. It highlights the nuances in drug categories and emphasizes the significance of precise drug naming and classification in clinical practice to ensure appropriate drug selection and management for patients.
In this context, the correct answer is C) Amphetamine because amphetamine is not a catecholamine. While amphetamine does exert sympathomimetic effects by increasing the release of norepinephrine and dopamine, it lacks the catechol structure necessary to be classified as a catecholamine.
A) Adrenaline (epinephrine) and B) Noradrenaline (norepinephrine) are both catecholamines with the characteristic catechol ring structure, making them true members of this group. D) Isoprenaline (isoproterenol) is also a catecholamine with a similar structure to adrenaline and noradrenaline.
Educationally, this question helps reinforce the importance of understanding the chemical structures and classifications of drugs in pharmacology. It highlights the nuances in drug categories and emphasizes the significance of precise drug naming and classification in clinical practice to ensure appropriate drug selection and management for patients.